Care of patients with CF | Page 8 | European Cystic Fibrosis Society (ECFS)

Long-term health effects of real-world use of ivacaftor by people with cystic fibrosis who have non-G551D-CFTR gating mutations

High blood eosinophil counts are linked with worse symptoms in adults with cystic fibrosis

Club cell secretory protein is reduced in children with cystic fibrosis who have severe lung disease

CFTR modulators: A case where Triple therapy induced rash resolved on its own, without stopping the drug

Vitamin D and liver stiffness measurements – Are they players in Cystic Fibrosis liver disease?

Using inhaled aztreonam in the treatment of exacerbations of cystic fibrosis

Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients

Laboratory reporting on the clinical spectrum of CFTR p.Arg117His: still room for improvement

Adjusting the dose of triple therapy (Elexacaftor/Tezacaftor/Ivacaftor) to reduce mental health side effects

Patients with F508del/5T;TG12 CFTR genotype

first
previous
…
4
5
6
7
8
9
10
11
12
…
next
last